Estados Unidos · Plataformas y datos · Stocktwits
Biotech Dealmaker: Early-Stage Platforms And Tools Draw Capital As Full Buyouts Remain On The Sidelines This Week
Resumen detallado
Large drugmakers and specialized investors continued to favor targeted capability additions, asset purchases, and co-funding arrangements over outright buyouts of late-stage…
MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (stocktwits.com)
